Works matching DE "ARIPIPRAZOLE"

Results: 2244

Atypical presentation of domperidone-induced galactorrhea.

Published in:

Indian Journal of Pharmacology, 2022, v. 54, n. 5, p. 381, doi. 10.4103/ijp.ijp_351_22

By:

Yedla, Deepthi;
Sharmila, Vijayan

Publication type:

Article

Clozapine-induced seizure.

Published in:

Indian Journal of Pharmacology, 2019, v. 51, n. 6, p. 410, doi. 10.4103/ijp.IJP_403_18

By:

Borah, Ankur;
Kalita, Abhijit;
Dutta, Satya

Publication type:

Article

Effects of clozapine and haloperidol treatment on plasma concentrations of androgen hormones and androgendependent organ changes in rats.

Published in:

Indian Journal of Pharmacology, 2019, v. 51, n. 4, p. 269, doi. 10.4103/ijp.IJP_145_18

By:

Samadi, Afshin;
Isikhan, Selen;
Ansari, Mohammad;
Samadi, Mahshid;
Sabuncuoglu, Suna

Publication type:

Article

Aripiprazole as a treatment option for clozapine-induced enuresis.

Published in:

2015

By:

Palaniappan, Pradeep

Publication type:

Case Study

Aripiprazole monotherapy in an adolescent worsens psychosis.

Published in:

Indian Journal of Pharmacology, 2013, v. 45, n. 2, p. 195, doi. 10.4103/0253-7613.108322

By:

Panigrahi, Mahima;
Padhy, Susanta Kumar;
Rathi, Rajesh

Publication type:

Article

Effect of combination of aripiprazole with carbamazepine and fluvoxamine on liver functions in experimental animal.

Published in:

Indian Journal of Pharmacology, 2013, v. 45, n. 2, p. 121, doi. 10.4103/0253-7613.108280

By:

Shastry, Chakrakodi S.;
Shafeeque, Aboobakar A.;
Ashwathnarayana, Badavanahalli J.

Publication type:

Article

Role of aripiprazole in the management of behavioural and psychological symptoms of dementia: a narrative review.

Published in:

Psychogeriatrics, 2022, v. 22, n. 1, p. 137, doi. 10.1111/psyg.12787

By:

Álvarez‐Fernández, Baldomero;
Bernal‐López, M. Rosa;
Gómez‐Huelgas, Ricardo

Publication type:

Article

Comparison of treatment retention between risperidone long‐acting injection, paliperidone palmitate, and aripiprazole once‐monthly in elderly patients with schizophrenia.

Published in:

2022

By:

Suzuki, Hidenobu;
Hibino, Hiroyuki

Publication type:

Letter to the Editor

A case of oral cenesthopathy in which dementia with Lewy bodies developed during treatment.

Published in:

2020

By:

Umezaki, Yojiro;
Asada, Takashi;
Naito, Toru;
Toyofuku, Akira

Publication type:

Case Study

A case of frontotemporal dementia with sexual disinhibition controlled by aripiprazole.

Published in:

Psychogeriatrics, 2017, v. 17, n. 6, p. 509, doi. 10.1111/psyg.12261

By:

Nomoto, Hiroshi;
Matsubara, Yoichiro;
Ichimiya, Yosuke;
Arai, Heii

Publication type:

Article

Use of aripiprazole for delirium in the elderly: a short review.

Published in:

Psychogeriatrics, 2015, v. 15, n. 1, p. 75, doi. 10.1111/psyg.12088

By:

Kirino, Eiji

Publication type:

Article

Cryogel Carriers Comprising β‐Cyclodextrin Moieties for Improved Solubilization and Delivery of Aripiprazole.

Published in:

Macromolecular Chemistry & Physics, 2021, v. 222, n. 7, p. 1, doi. 10.1002/macp.202100004

By:

Danov, Yavor;
Georgieva, Dilyana;
Mihaylova, Rositsa;
Kostova, Bistra;
Petrov, Petar D.

Publication type:

Article

Effects of atypical antipsychotics on serum asprosin level and other metabolic parameters in patients with schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2024, v. 39, n. 5, p. 1, doi. 10.1002/hup.2907

By:

Amini, Kiumarth;
Motallebi, Mohammad‐Javad;
Bakhtiari, Kimia;
Hajmiri, Minoo Sadat;
Zamanirafe, Maryam;
Sharifikia, Mahdis;
Ranjbar, Akram;
Keshavarzi, Amir;
Mirjalili, Mahtabalsadat;
Mehrpooya, Maryam

Publication type:

Article

The use of antipsychotics in obsessive compulsive disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2024, v. 39, n. 3, p. 1, doi. 10.1002/hup.2893

By:

Conti, Dario;
Girone, Nicolaja;
Boscacci, Maria;
Casati, Lorenzo;
Cassina, Niccolò;
Cerolini, Lucia;
Giacovelli, Luca;
Viganò, Caterina;
Conde, Marian Mora;
Cremaschi, Laura;
Dell'Osso, Bernardo M.

Publication type:

Article

Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2024, v. 39, n. 2, p. 1, doi. 10.1002/hup.2880

By:

Zhang, Qun;
Liu, Ziping;
Wang, Ting;
Yu, Min;
Li, Xiaoqian

Publication type:

Article

The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2023, v. 38, n. 3, p. 1, doi. 10.1002/hup.2863

By:

Pilunthanakul, Thanita;
Ting, Mable Quek Jing;
Lee, Jimmy;
Gupta, Bhanu

Publication type:

Article

A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2023, v. 38, n. 1, p. 1, doi. 10.1002/hup.2857

By:

Bıçakcı Ay, Şule;
Oğuz, Kader K.;
Özçelik Eroğlu, Elçin;
Has, Arzu Ceylan;
Ertuğrul, Aygün

Publication type:

Article

Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 6, p. 1, doi. 10.1002/hup.2854

By:

Ferrari, Marco;
Godio, Marco;
Martini, Stefano;
Callegari, Camilla;
Cosentino, Marco;
Marino, Franca

Publication type:

Article

Efficacy of tiapride in the treatment of psychiatric disorders: A systematic review.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 5, p. 1, doi. 10.1002/hup.2842

By:

Zangani, Caroline;
Giordano, Barbara;
Stein, Hans‐Christian;
Bonora, Stefano;
Ostinelli, Edoardo Giuseppe;
D'Agostino, Armando

Publication type:

Article

Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 2, p. 1, doi. 10.1002/hup.2821

By:

Miola, Alessandro;
Fornaro, Michele;
Sambataro, Fabio;
Solmi, Marco

Publication type:

Article

Characteristics of antipsychotic drug‐induced hypothermia in psychogeriatric inpatients.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 2, p. 1, doi. 10.1002/hup.2816

By:

Kamp, Daniel;
Paschali, Myrella;
Bouanane, Annabelle;
Christl, Julia;
Supprian, Tillmann;
Meisenzahl‐Lechner, Eva;
Kojda, Georg;
Lange‐Asschenfeldt, Christian

Publication type:

Article

Response efficacy and heterogeneity of antipsychotic drugs in schizophrenia: Systemic review and meta‐analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 1, p. 1, doi. 10.1002/hup.2808

By:

Zhang, Xin;
Tang, Jia;
Zhang, Xue;
Abdelrahim, Mohamed E. A.;
Yin, Zubin

Publication type:

Article

The first patient to receive olanzapine: A recollection.

Published in:: Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 6, p. 1, doi. 10.1002/hup.2823
Publication type:: Article

Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 6, p. 1, doi. 10.1002/hup.2804

By:

Takeuchi, Hiroyoshi;
Takekita, Yoshiteru;
Hori, Hikaru;
Oya, Kazuto;
Miura, Itaru;
Hashimoto, Naoki;
Yasui‐Furukori, Norio

Publication type:

Article

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 6, p. 1, doi. 10.1002/hup.2801

By:

Zangani, Caroline;
Giordano, Barbara;
Stein, Hans‐Christian;
Bonora, Stefano;
D'Agostino, Armando;
Ostinelli, Edoardo Giuseppe

Publication type:

Article

Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 4, p. 1, doi. 10.1002/hup.2783

By:

Cascino, Giammarco;
D'Agostino, Giulia;
Monteleone, Alessio Maria;
Marciello, Francesca;
Caivano, Vito;
Monteleone, Palmiero;
Maj, Mario

Publication type:

Article

Could N‐acetylcysteine improve the safety of clozapine?

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 2, p. 1, doi. 10.1002/hup.2769

By:

Chrétien, Basile;
Fedrizzi, Sophie;
Lelong‐Boulouard, Véronique;
Sassier, Marion;
Alexandre, Joachim;
Dolladille, Charles

Publication type:

Article

Medication management of antipsychotic treatment in schizophrenia—A narrative review.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 2, p. 1, doi. 10.1002/hup.2765

By:

Isohanni, Matti;
Jääskeläinen, Erika;
Miller, Brian J.;
Hulkko, Anja;
Tiihonen, Jari;
Möller, Hans‐Jurgen;
Hartikainen, Sirpa;
Huhtaniska, Sanna;
Lieslehto, Johannes

Publication type:

Article

Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 2, p. 1, doi. 10.1002/hup.2764

By:

Adachi, Naoto;
Azekawa, Takaharu;
Edagawa, Kouji;
Goto, Eiichiro;
Hongo, Seiji;
Kato, Masaki;
Katsumoto, Eiichi;
Kikuchi, Toshiaki;
Kubota, Yukihisa;
Miki, Kazuhira;
Nakagawa, Atsuo;
Tsuboi, Takashi;
Ueda, Hitoshi;
Watanabe, Koichiro;
Watanabe, Yoichiro;
Yasui‐Furukori, Norio;
Yoshimura, Reiji

Publication type:

Article

Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2021, v. 36, n. 2, p. 1, doi. 10.1002/hup.2763

By:

Karlović, Dalibor;
Silić, Ante;
Crnković, Danijel;
Peitl, Vjekoslav

Publication type:

Article

Association between dopamine beta‐hydroxylase polymorphism and attention function in suicide attempters with chronic schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 6, p. 1, doi. 10.1002/hup.2755

By:

Hui, Li;
Hu, Wei Ming;
Zhu, Zhen Hua;
Gao, Song Tian;
Han, Mei;
Fan, Yu;
Tian, Qing;
Yin, Xu Yuan;
Yuan, Ying;
Jiang, Cai Xia;
Yin, Guang Zhong;
Jia, Qiu Fang;
Zhang, Xiang Yang

Publication type:

Article

Differential effects of different antipsychotic drugs on cognitive function in patients with chronic schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 6, p. 1, doi. 10.1002/hup.2754

By:

Dong, Rui;
Yuan, Lian;
Yang, Yong;
Du, Xiang‐Dong;
Jia, Qiufang;
Dillon, Brett A.;
Yu, Liling;
Zhang, Xiang Yang

Publication type:

Article

Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 6, p. 1, doi. 10.1002/hup.2752

By:

Lim, Wai Kwong;
Chew, Qian Hui;
He, Yan‐Ling;
Si, Tian‐Mei;
Chiu, Fung‐Kum Helen;
Xiang, Yu‐Tao;
Kato, Takahiro A.;
Kanba, Shigenobu;
Shinfuku, Naotaka;
Lee, Min‐Soo;
Park, Seon‐Cheol;
Park, Yong‐Chon;
Chong, Mian‐Yoon;
Lin, Shih‐Ku;
Yang, Shu‐Yu;
Tripathi, Adarsh;
Avasthi, Ajit;
Grover, Sandeep;
Kallivayalil, Roy Abraham;
Udomratn, Pichet

Publication type:

Article

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 4, p. 1, doi. 10.1002/hup.2737

By:

Fedorenko, Olga Yu.;
Paderina, Diana Z.;
Loonen, Anton J. M.;
Pozhidaev, Ivan V.;
Boiko, Anastasiia S.;
Kornetova, Elena G.;
Bokhan, Nikolay A.;
Wilffert, Bob;
Ivanova, Svetlana A.

Publication type:

Article

Drug‐induced tics: An observational postmarketing study.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 4, p. 1, doi. 10.1002/hup.2734

By:

Touafchia, Davy;
Montastruc, François;
Lapeyre‐Mestre, Maryse;
Rousseau, Vanessa;
Chebane, Leila;
Revet, Alexis

Publication type:

Article

Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2020, v. 35, n. 1, p. N.PAG, doi. 10.1002/hup.2718

By:

Mehta, Neeti D.;
Won, Michelle J.;
Babin, Shelly L.;
Patel, Saumil S.;
Wassef, Adel A.;
Chuang, Alice Z.;
Sereno, Anne B.

Publication type:

Article

The effect of baseline antipsychotic status on the 12‐month outcome in initially stabilized patients with schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 5, p. 1, doi. 10.1002/hup.2712

By:

Fountoulakis, Konstantinos N.;
Panagiotidis, Panagiotis;
Nimatoudis, Ioannis

Publication type:

Article

Low‐ and high‐dose aripiprazole augmentation and plasma levels of homovanillic acid in major depressive disorder: A randomized, open‐label study.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 3, p. N.PAG, doi. 10.1002/hup.2696

By:

Horikoshi, Sho;
Miura, Itaru;
Ichinose, Mizue;
Yamamoto, Shinnosuke;
Ito, Masashi;
Watanabe, Kenya;
Kanno‐Nozaki, Keiko;
Kaneko, Haruka;
Yabe, Hirooki

Publication type:

Article

The effects of different periods of co‐administration of oral and long‐acting injectable aripiprazole: A propensity score analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 1, p. N.PAG, doi. 10.1002/hup.2681

By:

Iwata, Nakao;
Hatano, Masakazu;
Kamei, Hiroyuki;
Yamada, Shigeki;
Makino, Shinya;
Hanya, Manako;
Takeuchi, Ippei;
Tozawa, Kaori

Publication type:

Article

Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2018, v. 33, n. 3, p. 1, doi. 10.1002/hup.2658

By:

Girardi, Paolo;
Del Casale, Antonio;
Rapinesi, Chiara;
Kotzalidis, Georgios D.;
Splendori, Francesca;
Verzura, Claudio;
Trovini, Giada;
Sorice, Serena;
Carrus, Dario;
Mancinelli, Iginia;
Comparelli, Anna;
De Filippis, Sergio;
Francomano, Antonio;
Ballerini, Andrea;
Marcellusi, Andrea;
Mennini, Francesco S.;
Ducci, Giuseppe;
Sani, Gabriele;
Pompili, Maurizio;
Brugnoli, Roberto

Publication type:

Article

Pharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 4, p. 268, doi. 10.1002/hup.2535

By:

Dundar, Yenal;
Greenhalgh, Janette;
Richardson, Marty;
Dwan, Kerry

Publication type:

Article

Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 1, p. 11, doi. 10.1002/hup.2498

By:

Zheng, Wei;
Li, Xian‐Bin;
Xiang, Ying‐Qiang;
Zhong, Bao‐Liang;
Chiu, Helen F. K.;
Ungvari, Gabor S.;
Ng, Chee H.;
Lok, Grace K. I.;
Xiang, Yu‐Tao

Publication type:

Article

Serial pharmacological prescribing practices for tic management in Tourette syndrome.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 6, p. 435, doi. 10.1002/hup.2495

By:

Farag, Mena;
Stern, Jeremy S.;
Simmons, Helen;
Robertson, Mary M.

Publication type:

Article

Switching antipsychotics to aripiprazole or blonanserin and plasma monoamine metabolites levels in patients with schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 2, p. 199, doi. 10.1002/hup.2386

By:

Miura, Itaru;
Shiga, Tetsuya;
Katsumi, Akihiko;
Kanno‐Nozaki, Keiko;
Mashiko, Hirobumi;
Niwa, Shin‐Ichi;
Yabe, Hirooki

Publication type:

Article

Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 38, doi. 10.1002/hup.2366

By:

Roffeei, Siti Norsyuhada;
Reynolds, Gavin P.;
Zainal, Nor Zuraida;
Said, Mas Ayu;
Hatim, Ahmad;
Aida, Syarinaz Ahmad;
Mohamed, Zahurin

Publication type:

Article

Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 94, doi. 10.1002/hup.2277

By:

Suzuki, Yutaro;
Sugai, Takuro;
Fukui, Naoki;
Watanabe, Junzo;
Ono, Shin;
Tsuneyama, Nobuto;
Saito, Mami;
Someya, Toshiyuki

Publication type:

Article

Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes ( in vitro study).

Published in:

Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 1, doi. 10.1002/hup.2272

By:

Miljević, Čedo;
Nikolić‐Kokić, Aleksandra;
Nikolić, Milan;
Niketić, Vesna;
Spasić, Mihajlo B.;
Lečić‐Toševski, Dušica;
Blagojević, Duško

Publication type:

Article

Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 6, p. 605, doi. 10.1002/hup.2270

By:

Zhang, Yinbo;
Dai, Guangzhi

Publication type:

Article

Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 4, p. 364, doi. 10.1002/hup.2235

By:

Neuner, Irene;
Nordt, Carlos;
Schneider, Frank;
Kawohl, Wolfram

Publication type:

Article

Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 1, p. 33, doi. 10.1002/hup.1257

By:

Yoshimura, Reiji;
Hori, Hikaru;
Ikenouchi-Sugita, Atsuko;
Umene-Nakano, Wakako;
Katsuki, Asuka;
Hayashi, Kenji;
Atake, Kiyokazu;
Tomita, Masaru;
Nakamura, Jun

Publication type:

Article